Aus HL7 Austria MediaWiki
Hauptseite > 1.2.40.0.34.10.44/static-2015-10-06T000000
Id | 1.2.40.0.34.10.44 | Gültigkeit | gültig ab 2015‑10‑06 |
---|
Status | Veraltet | Versions-Label | 3.3 |
---|
Name | ELGA_Laborparameter | Anzeigename | ELGA_Laborparameter |
---|
3 Quell-Codesysteme | 1.2.40.0.34.5.11 2.16.840.1.113883.6.1 2.16.840.1.113883.5.1008 |
---|
Level/ Typ | Code | Anzeigename | Codesystem |
---|
0‑S | 100 | Blutgruppenserologie | 1.2.40.0.34.5.11 | 1‑S | 01850 | Blutgruppenserologie | 1.2.40.0.34.5.11 | 2‑L | 883-9 | Blutgruppe AB0 | 2.16.840.1.113883.6.1 | 2‑L | V00432-7 | Blutgruppe AB0 Kontr | 1.2.40.0.34.5.11 | 2‑L | 57743-7 | Blutgruppe AB0 Best. | 2.16.840.1.113883.6.1 | 2‑L | 51892-8 | Blutgruppe AB0 /BCO | 2.16.840.1.113883.6.1 | 2‑L | 14580-5 | Blutgruppe AB0 Neug. | 2.16.840.1.113883.6.1 | 2‑L | 882-1 | Blutgruppe AB0 + Rh | 2.16.840.1.113883.6.1 | 2‑L | V00434-3 | Blutgr. AB0+Rh Kontr | 1.2.40.0.34.5.11 | 2‑L | V00433-5 | Blutgruppe AB0+Rh Bt | 1.2.40.0.34.5.11 | 2‑L | 34474-7 | Blutgr. AB0+Rh /BCO | 2.16.840.1.113883.6.1 | 2‑L | 19057-9 | Blutgr. AB0+Rh Neug. | 2.16.840.1.113883.6.1 | 2‑L | 10331-7 | Rhesusfaktor | 2.16.840.1.113883.6.1 | 2‑L | V00435-0 | Rhesusfaktor Kontr. | 1.2.40.0.34.5.11 | 2‑L | 34961-3 | Rhesusfaktor Best. | 2.16.840.1.113883.6.1 | 2‑L | 14906-2 | Rhesusfaktor /BCO | 2.16.840.1.113883.6.1 | 2‑L | 14908-8 | Rhesusfaktor Neugeb. | 2.16.840.1.113883.6.1 | 2‑L | 890-4 | Blutgr. AK-Screen | 2.16.840.1.113883.6.1 | 2‑L | 888-8 | Blutgruppen AK-Diff. | 2.16.840.1.113883.6.1 | 2‑L | 906-8 | Blutgruppen AG-Best. | 2.16.840.1.113883.6.1 | 2‑L | 907-6 | EK. Blutgr. AG-Best. | 2.16.840.1.113883.6.1 | 2‑L | 1250-0 | Kreuzprobe (major) | 2.16.840.1.113883.6.1 | 2‑L | 1007-4 | DCT polyspez. | 2.16.840.1.113883.6.1 | 2‑L | 55776-9 | DCT IgG-spez. | 2.16.840.1.113883.6.1 | 2‑L | 55775-1 | DCT IgA-spez. | 2.16.840.1.113883.6.1 | 2‑L | 55777-7 | DCT IgM-spez. | 2.16.840.1.113883.6.1 | 2‑L | 56471-6 | DCT C3c-spez. | 2.16.840.1.113883.6.1 | 2‑L | 55774-4 | DCT C3d-spez. | 2.16.840.1.113883.6.1 | 2‑L | 1008-2 | ICT polyspez. | 2.16.840.1.113883.6.1 | 2‑L | 34477-0 | BG. AK-Diff.Elution | 2.16.840.1.113883.6.1 | 2‑L | 61406-5 | Blutgr.-AK Titer | 2.16.840.1.113883.6.1 | 2‑L | 13310-8 | Blutgr. K-Antigen | 2.16.840.1.113883.6.1 | 2‑L | 972-0 | Blutgr. Dweak-AG | 2.16.840.1.113883.6.1 | 2‑L | 1303-7 | BG-Serumgegenprobe | 2.16.840.1.113883.6.1 | 2‑L | 817-7 | Blutgr. A AK | 2.16.840.1.113883.6.1 | 2‑L | 913-4 | Blutgr. B AK | 2.16.840.1.113883.6.1 | 2‑L | 14658-9 | Kälteagglutinine Ttr | 2.16.840.1.113883.6.1 | 2‑L | 5097-1 | Kälteagglutinine ql | 2.16.840.1.113883.6.1 | 1‑S | 01860 | HLA-Diagnostik | 1.2.40.0.34.5.11 | 2‑L | 42675-9 | HLA-Antigene | 2.16.840.1.113883.6.1 | 2‑L | 4821-5 | HLA-B27 ql. | 2.16.840.1.113883.6.1 | 2‑L | 26028-1 | HLA-B27 (Flowzytom.) | 2.16.840.1.113883.6.1 | 2‑L | 45023-9 | HLA Typ Zöliakie | 2.16.840.1.113883.6.1 | 1‑S | 01870 | HPA-Diagnostik | 1.2.40.0.34.5.11 | 2‑L | 50604-8 | HPA-Befund | 2.16.840.1.113883.6.1 | 0‑S | 200 | Blutgasanalytik | 1.2.40.0.34.5.11 | 1‑S | 02060 | Blutgasanalyse arteriell | 1.2.40.0.34.5.11 | 2‑L | 24336-0 | BGA Anf. art. | 2.16.840.1.113883.6.1 | 2‑L | 2744-1 | pH art. | 2.16.840.1.113883.6.1 | 2‑L | 2019-8 | pCO2 art. | 2.16.840.1.113883.6.1 | 2‑L | 2703-7 | pO2 art. | 2.16.840.1.113883.6.1 | 2‑L | 19214-6 | pO2-50 art. | 2.16.840.1.113883.6.1 | 2‑L | 2714-4 | FO2-Hb art. | 2.16.840.1.113883.6.1 | 2‑L | 72326-2 | Shunt-Vol. fkt. art. | 2.16.840.1.113883.6.1 | 2‑L | 2708-6 | O2-Sättigung art. | 2.16.840.1.113883.6.1 | 2‑L | 59413-5 | O2-Sättigung art. pT | 2.16.840.1.113883.6.1 | 2‑L | 1925-7 | Base excess art. | 2.16.840.1.113883.6.1 | 2‑L | 19235-1 | SBEC art. | 2.16.840.1.113883.6.1 | 2‑L | 1960-4 | Bikarbonat art. | 2.16.840.1.113883.6.1 | 2‑L | 19230-2 | Bikarbonat Std. BA | 2.16.840.1.113883.6.1 | 2‑L | 2518-9 | Laktat art. | 2.16.840.1.113883.6.1 | 2‑L | 32717-1 | Natrium art. | 2.16.840.1.113883.6.1 | 2‑L | 32713-0 | Kalium art. | 2.16.840.1.113883.6.1 | 2‑L | 34581-9 | Calcium ion. art. | 2.16.840.1.113883.6.1 | 2‑L | 41650-3 | Chlorid art. | 2.16.840.1.113883.6.1 | 2‑L | 59827-6 | Bilirubin art. | 2.16.840.1.113883.6.1 | 2‑L | 41651-1 | Glucose art. | 2.16.840.1.113883.6.1 | 2‑L | 21232-4 | Kreatinin art. | 2.16.840.1.113883.6.1 | 2‑L | 32354-3 | Hct art. | 2.16.840.1.113883.6.1 | 1‑S | 02070 | Hb-Derivate arteriell | 1.2.40.0.34.5.11 | 2‑L | 30313-1 | Hämoglobin art. | 2.16.840.1.113883.6.1 | 2‑L | 19225-2 | Deoxy.Hämoglob. art. | 2.16.840.1.113883.6.1 | 2‑L | 2030-5 | Carboxyhämoglob. art | 2.16.840.1.113883.6.1 | 2‑L | 2615-3 | Methämoglobin art. | 2.16.840.1.113883.6.1 | 2‑L | V00230 | Sulfhämoglobin art. | 1.2.40.0.34.5.11 | 1‑S | 02080 | Blutgasanalyse venös | 1.2.40.0.34.5.11 | 2‑L | 24339-4 | BGA Anf. ven. | 2.16.840.1.113883.6.1 | 2‑L | 2746-6 | pH ven. | 2.16.840.1.113883.6.1 | 2‑L | 2021-4 | pCO2 ven. | 2.16.840.1.113883.6.1 | 2‑L | 2705-2 | pO2 ven. | 2.16.840.1.113883.6.1 | 2‑L | 2716-9 | FO2-Hb ven. | 2.16.840.1.113883.6.1 | 2‑L | 2711-0 | O2-Sättigung ven. | 2.16.840.1.113883.6.1 | 2‑L | 1927-3 | Base excess ven. | 2.16.840.1.113883.6.1 | 2‑L | 14627-4 | Bikarbonat ven. | 2.16.840.1.113883.6.1 | 2‑L | 19232-8 | Bikarbonat Std. BV | 2.16.840.1.113883.6.1 | 2‑L | 2519-7 | Laktat ven. | 2.16.840.1.113883.6.1 | 2‑L | 39791-9 | Natrium ven. | 2.16.840.1.113883.6.1 | 2‑L | 39789-3 | Kalium ven. | 2.16.840.1.113883.6.1 | 2‑L | 41649-5 | Chlorid ven. | 2.16.840.1.113883.6.1 | 2‑L | 59828-4 | Bilirubin ven. | 2.16.840.1.113883.6.1 | 2‑L | 41652-9 | Glucose ven. | 2.16.840.1.113883.6.1 | 2‑L | 41654-5 | Hct ven. | 2.16.840.1.113883.6.1 | 1‑S | 02090 | Hb-Derivate venös | 1.2.40.0.34.5.11 | 2‑L | 30350-3 | Hämoglobin ven. | 2.16.840.1.113883.6.1 | 2‑L | 19227-8 | Deoxy.Hämoglob. ven. | 2.16.840.1.113883.6.1 | 2‑L | 2032-1 | CO-Hämoglobin ven. | 2.16.840.1.113883.6.1 | 2‑L | 2617-9 | Methämoglobin ven. | 2.16.840.1.113883.6.1 | 2‑L | V00229 | Sulfhämoglobin ven. | 1.2.40.0.34.5.11 | 1‑S | 02100 | Blutgasanalyse kapillär | 1.2.40.0.34.5.11 | 2‑L | 24337-8 | BGA Anf. Kap. | 2.16.840.1.113883.6.1 | 2‑L | 2745-8 | pH kap. | 2.16.840.1.113883.6.1 | 2‑L | 11558-4 | pH kap. | 2.16.840.1.113883.6.1 | 2‑L | 2020-6 | pCO2 kap. | 2.16.840.1.113883.6.1 | 2‑L | 2704-5 | pO2 kap. | 2.16.840.1.113883.6.1 | 2‑L | 50211-2 | F-Shuntvolumen kap. | 2.16.840.1.113883.6.1 | 2‑L | 2709-4 | O2-Sättigung kap. | 2.16.840.1.113883.6.1 | 2‑L | 1926-5 | Base excess kap. | 2.16.840.1.113883.6.1 | 2‑L | 19236-9 | SBEC kap. | 2.16.840.1.113883.6.1 | 2‑L | 1961-2 | Bikarbonat kap. | 2.16.840.1.113883.6.1 | 2‑L | 19239-3 | Laktat kap. | 2.16.840.1.113883.6.1 | 2‑L | 39792-7 | Natrium kap. | 2.16.840.1.113883.6.1 | 2‑L | 39790-1 | Kalium kap. | 2.16.840.1.113883.6.1 | 2‑L | 41644-6 | Calcium ion. Kap. | 2.16.840.1.113883.6.1 | 2‑L | 51590-8 | Chlorid kap. | 2.16.840.1.113883.6.1 | 2‑L | 48421-2 | CRP BK | 2.16.840.1.113883.6.1 | 2‑L | V00453-3 | Bilirubin kap. | 1.2.40.0.34.5.11 | 2‑L | 32016-8 | Glucose kap. | 2.16.840.1.113883.6.1 | 2‑L | V00443-4 | Kreatinin kap. | 1.2.40.0.34.5.11 | 1‑S | 02110 | Hb-Derivate kapillär | 1.2.40.0.34.5.11 | 2‑L | 30352-9 | Hämoglobin kap. | 2.16.840.1.113883.6.1 | 2‑L | 2715-1 | Oxygen.Hämoglob. kap. | 2.16.840.1.113883.6.1 | 2‑L | 19226-0 | Deoxy.Hämoglobin kap. | 2.16.840.1.113883.6.1 | 2‑L | 2031-3 | CO-Hämoglobin kap. | 2.16.840.1.113883.6.1 | 2‑L | 2616-1 | Methämoglobin kap. | 2.16.840.1.113883.6.1 | 2‑L | V00228 | Sulfhämoglobin kap. | 1.2.40.0.34.5.11 | 1‑S | 02120 | Hb-Derivate, gemischtvenös (Rechtsherzkatheter) | 1.2.40.0.34.5.11 | 2‑L | 30351-1 | Hämoglobin gev. | 2.16.840.1.113883.6.1 | 2‑L | 34969-6 | Oxygen.Hämoglob. Gev. | 2.16.840.1.113883.6.1 | 2‑L | 19228-6 | Deoxy.Hämoglobin gev. | 2.16.840.1.113883.6.1 | 2‑L | 41648-7 | CO-Hämoglobin gev. | 2.16.840.1.113883.6.1 | 2‑L | 41607-3 | Methämoglobin gev. | 2.16.840.1.113883.6.1 | 2‑L | V00227 | Sulfhämoglobin gev. | 1.2.40.0.34.5.11 | 1‑S | 02130 | BGA Sonstiges | 1.2.40.0.34.5.11 | 2‑L | 8310-5 | Körpertemperatur | 2.16.840.1.113883.6.1 | 2‑L | V00276 | Kommentar BGA | 1.2.40.0.34.5.11 | 2‑L | 2947-0 | Natrium/B | 2.16.840.1.113883.6.1 | 2‑L | 6298-4 | Kalium/B | 2.16.840.1.113883.6.1 | 2‑L | 1994-3 | Calcium ionisiert/B | 2.16.840.1.113883.6.1 | 2‑L | 38483-4 | Kreatinin /B | 2.16.840.1.113883.6.1 | 2‑L | V00464-0 | AaDO2 | 1.2.40.0.34.5.11 | 2‑L | 19991-9 | AaDO2 | 2.16.840.1.113883.6.1 | 0‑S | 300 | Hämatologie | 1.2.40.0.34.5.11 | 1‑S | 03010 | Blutbild | 1.2.40.0.34.5.11 | 2‑L | 57021-8 | Blutbild | 2.16.840.1.113883.6.1 | 2‑L | V00197 | Blutbild 37 Grad | 1.2.40.0.34.5.11 | 2‑L | 57782-5 | Blutbild+Man. Diff. | 2.16.840.1.113883.6.1 | 2‑L | 55429-5 | kleines Blutbild | 2.16.840.1.113883.6.1 | 2‑L | 50262-5 | Retikulozyten | 2.16.840.1.113883.6.1 | 2‑L | 26464-8 | Leukozyten | 2.16.840.1.113883.6.1 | 2‑L | 26515-7 | Thrombozyten | 2.16.840.1.113883.6.1 | 2‑L | 778-1 | Thrombozyten abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 26453-1 | Erythrozyten | 2.16.840.1.113883.6.1 | 2‑L | 718-7 | Hämoglobin | 2.16.840.1.113883.6.1 | 2‑L | 20570-8 | Hämatokrit | 2.16.840.1.113883.6.1 | 2‑L | 30428-7 | MCV | 2.16.840.1.113883.6.1 | 2‑L | 28539-5 | MCH | 2.16.840.1.113883.6.1 | 2‑L | 28540-3 | MCHC | 2.16.840.1.113883.6.1 | 2‑L | 30385-9 | RDW-CV | 2.16.840.1.113883.6.1 | 2‑L | 30384-2 | RDW-SD | 2.16.840.1.113883.6.1 | 2‑L | 14196-0 | Retikulozyten abs. | 2.16.840.1.113883.6.1 | 2‑L | 4679-7 | Retikulozyten rel. | 2.16.840.1.113883.6.1 | 2‑L | 40665-2 | Retikulozyt. abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 31112-6 | Retikulozyt. rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 32349-3 | Mittelfraktion abs. | 2.16.840.1.113883.6.1 | 2‑L | 32350-1 | Mittelfraktion rel. | 2.16.840.1.113883.6.1 | 2‑L | 32154-7 | Baso+Eo+Mono abs. | 2.16.840.1.113883.6.1 | 2‑L | 32155-4 | Baso+Eo+Mono rel. | 2.16.840.1.113883.6.1 | 2‑L | 26499-4 | Neutroph. Gran. abs. | 2.16.840.1.113883.6.1 | 2‑L | 26474-7 | Lymphozyten abs. | 2.16.840.1.113883.6.1 | 2‑L | 26484-6 | Monozyten abs. | 2.16.840.1.113883.6.1 | 2‑L | 26449-9 | Eosinophile Gr. abs. | 2.16.840.1.113883.6.1 | 2‑L | 26444-0 | Basophile Gr.abs. | 2.16.840.1.113883.6.1 | 2‑L | 51584-1 | Gran., unreife abs. | 2.16.840.1.113883.6.1 | 2‑L | 17789-9 | LUC abs. | 2.16.840.1.113883.6.1 | 2‑L | 26511-6 | Neutroph. Gran. rel. | 2.16.840.1.113883.6.1 | 2‑L | 26478-8 | Lymphozyten rel. | 2.16.840.1.113883.6.1 | 2‑L | 26485-3 | Monozyten rel. | 2.16.840.1.113883.6.1 | 2‑L | 26450-7 | Eosinophile Gr. rel. | 2.16.840.1.113883.6.1 | 2‑L | 30180-4 | Basophile Gr.rel. | 2.16.840.1.113883.6.1 | 2‑L | 38518-7 | Gran., unreife rel. | 2.16.840.1.113883.6.1 | 2‑L | 17788-1 | LUC rel. | 2.16.840.1.113883.6.1 | 2‑L | 51588-2 | Granulozyten abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 753-4 | Neutroph.Gr.abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 768-2 | Segmentkern. abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 763-3 | Stabkernige abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 739-3 | Metamyeloz. abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 748-4 | Myelozyten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 781-5 | Promyelozyt. abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 708-8 | Blasten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 732-8 | Lymphozyten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | V00043 | Akt.Lymphoz.abs.mi. | 1.2.40.0.34.5.11 | 2‑L | 734-4 | Atyp.Lymphoz.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 34993-6 | Kernschatten abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 35082-7 | LGL abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 24103-4 | Plasmazellen abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 33834-3 | Plasm.Lymphoz.ab.mi. | 2.16.840.1.113883.6.1 | 2‑L | 6863-5 | Prolymphozyt.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 24107-5 | Haarzellen abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 33856-6 | Sezary-Zel. abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 743-5 | Monozyten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 712-0 | Eosinoph.Gr.abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 705-4 | Basophile Gr.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51585-8 | Sonstige Zel.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 769-0 | Segmentkern. rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 764-1 | Stabkernige rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 28541-1 | Metamyeloz. rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 749-2 | Myelozyten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 783-1 | Promyelozyt. rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 709-6 | Blasten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 737-7 | Lymphozyten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | V00042 | Akt.Lymphoz.rel.mi. | 1.2.40.0.34.5.11 | 2‑L | 735-1 | Atyp.Lymphoz.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 733-6 | Atyp.Lymphoz.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 34992-8 | Kernschatten rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 7798-2 | Kernschatten ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 11275-5 | LGL rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 13047-6 | Plasmazellen rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 40743-7 | Plasmazellen ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 33835-0 | Plasm.Lymphoz.rl.mi. | 2.16.840.1.113883.6.1 | 2‑L | 6746-2 | Prolymphozyt.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 24106-7 | Haarzellen rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 33857-4 | Sezary-Zel. rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 744-3 | Monozyten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 714-6 | Eosinoph.Gr.rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 707-0 | Basophile Gr.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51586-6 | Sonstige Zel.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51644-3 | Megakar.kerne ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 5908-9 | Riesenthromb. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 7796-6 | Thromboz.aggr.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51640-1 | Thro.anisozyt.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 738-5 | Makrozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 51645-0 | Mikromegakary.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 765-8 | Hypersegment. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 803-7 | Toxische Gran.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 10378-8 | Polychromasie ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 779-9 | Poikilozytose ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 741-9 | Mikrozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 10376-2 | Megalozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 802-9 | Kugelzellen ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 728-6 | Hypochromasie ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 7793-3 | Howell-Jolly. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51630-2 | Fragmentozyt.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 800-3 | Fragmentozyt. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51638-5 | Ery.aggregate ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 11274-8 | Elliptozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 7790-9 | Echinozyten ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51589-0 | Dyserythrop. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 10377-0 | Bleistiftzel. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 703-9 | Basoph.Tüpfelung mi. | 2.16.840.1.113883.6.1 | 2‑L | 51583-3 | Anulozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 702-1 | Anisozytose ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 51582-5 | Anisochromas.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51639-3 | Akanthozyten rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 7789-1 | Akanthozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 7791-7 | Tränenzellen ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 10381-2 | Target-Zellen mi. | 2.16.840.1.113883.6.1 | 2‑L | 7797-4 | Geldrollenb. ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 10380-4 | Stomatozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 801-1 | Sichelzellen ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 30392-5 | Normoblast.(NRBC)ab. | 2.16.840.1.113883.6.1 | 2‑L | 19048-8 | Normoblast.(NRBC)Rt. | 2.16.840.1.113883.6.1 | 2‑L | 772-4 | Normobl.(NRBC)ab.mi. | 2.16.840.1.113883.6.1 | 2‑L | 18309-5 | Normobl.(NRBC)Rt.mi. | 2.16.840.1.113883.6.1 | 2‑L | 5909-7 | Blutausstr. Interpr. | 2.16.840.1.113883.6.1 | 2‑L | 42810-2 | Retikulozyten Hb | 2.16.840.1.113883.6.1 | 2‑L | 31111-8 | RPI | 2.16.840.1.113883.6.1 | 2‑L | 51636-9 | IRF(Ret.,unreif)abs. | 2.16.840.1.113883.6.1 | 2‑L | 33516-6 | IRF(Ret.,unreif)rel. | 2.16.840.1.113883.6.1 | 2‑L | 51634-4 | Reti,mittelreif abs. | 2.16.840.1.113883.6.1 | 2‑L | 34420-0 | Reti,mittelreif rel. | 2.16.840.1.113883.6.1 | 2‑L | 51635-1 | Reti., reif abs. | 2.16.840.1.113883.6.1 | 2‑L | 34419-2 | Reti., reife rel. | 2.16.840.1.113883.6.1 | 2‑L | 51643-5 | HLSc-Reti. abs. | 2.16.840.1.113883.6.1 | 2‑L | 51642-7 | HLSc-Reti. rel. | 2.16.840.1.113883.6.1 | 2‑L | 51637-7 | Thrombokrit | 2.16.840.1.113883.6.1 | 2‑L | 28542-9 | MPV | 2.16.840.1.113883.6.1 | 2‑L | 32207-3 | PDW-SD | 2.16.840.1.113883.6.1 | 2‑L | 51631-0 | PDW-CV | 2.16.840.1.113883.6.1 | 2‑L | 51632-8 | Retik.Thromboz.abs. | 2.16.840.1.113883.6.1 | 2‑L | 51633-6 | Retik.Thromboz.rel. | 2.16.840.1.113883.6.1 | 2‑L | 40741-1 | PLTCLU | 2.16.840.1.113883.6.1 | 2‑L | 50794-7 | Osm.E.R.Hämol.beginn | 2.16.840.1.113883.6.1 | 2‑L | 50795-4 | Osm.E.R.Totalhämol. | 2.16.840.1.113883.6.1 | 2‑L | 34964-7 | Osmot.E.R. Interpr. | 2.16.840.1.113883.6.1 | 2‑L | 12710-0 | Hämoglobinopath. Scr | 2.16.840.1.113883.6.1 | 2‑L | 4547-6 | Hämoglobin A1 | 2.16.840.1.113883.6.1 | 2‑L | 4551-8 | Hämoglobin A2 | 2.16.840.1.113883.6.1 | 2‑L | 4621-9 | Hämoglobin S | 2.16.840.1.113883.6.1 | 2‑L | 4579-9 | Hämoglobin F | 2.16.840.1.113883.6.1 | 2‑L | 1783-0 | Alk.Phosphataseindex | 2.16.840.1.113883.6.1 | 1‑S | 03020 | Knochenmark Morphologie | 1.2.40.0.34.5.11 | 2‑L | 38519-5 | KM Morphologie | 2.16.840.1.113883.6.1 | 2‑L | 11128-6 | Segm.Gran. rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11103-9 | Stabk.Gran. rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11111-2 | Metamyeloz.rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11114-6 | Myelozyten rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11120-3 | Promyeloz. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11113-8 | Myeloblasten rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11108-8 | Lymphozyten rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11118-7 | Plasmaz. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11112-0 | Monozyten rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11106-2 | Eos.Gran.rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11105-4 | Basoph.Gran.rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11150-0 | Blasten rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 51579-1 | Normoblast. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 51629-4 | Makroblast. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11124-5 | Proerythrobl.rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11110-4 | Megakaryozy.rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 51580-9 | Makrophagen rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 51581-7 | Sonst.Zellen rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 51268-1 | CD23 Zellen rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 13513-7 | Eisenfärbung /KM | 2.16.840.1.113883.6.1 | 2‑L | 11016-3 | Esterase-Fbg (unsp.) | 2.16.840.1.113883.6.1 | 2‑L | 9786-5 | PAS-Färbung | 2.16.840.1.113883.6.1 | 2‑L | 11018-9 | POX(Peroxidase)-Fbg | 2.16.840.1.113883.6.1 | 2‑L | 11020-5 | Saure-Phosphat.-Fbg | 2.16.840.1.113883.6.1 | 2‑L | 11019-7 | Sudan-Schwarz-Fbg | 2.16.840.1.113883.6.1 | 2‑L | 51628-6 | KM-Befundinterpr. | 2.16.840.1.113883.6.1 | 2‑L | 57764-3 | KM mikr. Bef.-Intpr. | 2.16.840.1.113883.6.1 | 1‑S | 03030 | Immunphänotypisierung | 1.2.40.0.34.5.11 | 2‑L | 45270-6 | Ak. Leukämiepanel FC | 2.16.840.1.113883.6.1 | 2‑L | 45269-8 | Chr.Leukämiepanel FC | 2.16.840.1.113883.6.1 | 2‑L | 54225-8 | Immunstatus | 2.16.840.1.113883.6.1 | 2‑L | 49120-9 | Immundefizienz Verl. | 2.16.840.1.113883.6.1 | 2‑L | 54228-2 | CLL Panel FC | 2.16.840.1.113883.6.1 | 2‑L | 54229-0 | T-Zell Panel FC | 2.16.840.1.113883.6.1 | 2‑L | 54227-4 | Ak. Lymphompanel FC | 2.16.840.1.113883.6.1 | 2‑L | 54226-6 | Lymphompanel FC | 2.16.840.1.113883.6.1 | 2‑L | V00116 | Flowzytometrie Blut | 1.2.40.0.34.5.11 | 2‑L | V00117 | Flowzytometrie BAL | 1.2.40.0.34.5.11 | 2‑L | V00118 | Flowzytometrie /L | 1.2.40.0.34.5.11 | 2‑L | V00119 | Flowzytometrie KM | 1.2.40.0.34.5.11 | 2‑L | V00120 | Flowzytometrie SM | 1.2.40.0.34.5.11 | 2‑L | 55164-8 | PNH-Diagnostik | 2.16.840.1.113883.6.1 | 2‑L | V00211 | Stammzell.(34+)[Leu] | 1.2.40.0.34.5.11 | 2‑L | 14136-6 | Stammzell.(34+) abs. | 2.16.840.1.113883.6.1 | 2‑L | V00065 | CD64 AG-D.[Ne.Gran.] | 1.2.40.0.34.5.11 | 2‑L | V00057 | CD64 AG-Zahl/Gran. | 1.2.40.0.34.5.11 | 2‑L | V00066 | HLA-DR AG-D.[Monoz.] | 1.2.40.0.34.5.11 | 2‑L | 30364-4 | Lymphozyten abs. FC | 2.16.840.1.113883.6.1 | 2‑L | 30365-1 | Lymphozyten rel. FC | 2.16.840.1.113883.6.1 | 2‑L | V00237 | Monozyten abs. FC | 1.2.40.0.34.5.11 | 2‑L | V00215 | Monozyten rel. FC | 1.2.40.0.34.5.11 | 2‑L | 30394-1 | Granulozyten abs. | 2.16.840.1.113883.6.1 | 2‑L | 30395-8 | Granulozyten rel. | 2.16.840.1.113883.6.1 | 2‑L | 8116-6 | B-Zellen (19+) abs. | 2.16.840.1.113883.6.1 | 2‑L | 8122-4 | T-Zellen (3+) abs. | 2.16.840.1.113883.6.1 | 2‑L | 24467-3 | Helfer-T-Z.(4+) abs. | 2.16.840.1.113883.6.1 | 2‑L | 14135-8 | Zytotox.T-Z.(8+)abs. | 2.16.840.1.113883.6.1 | 2‑L | 54218-3 | CD4/CD8-Ratio | 2.16.840.1.113883.6.1 | 2‑L | 26568-6 | aktiv.T-Z.(DR+)abs. | 2.16.840.1.113883.6.1 | 2‑L | 9728-7 | NK-Zellen abs. | 2.16.840.1.113883.6.1 | 2‑L | 42188-3 | NK-like T-Zell. abs. | 2.16.840.1.113883.6.1 | 2‑L | V00212 | B-Zellen (19+) [Leu] | 1.2.40.0.34.5.11 | 2‑L | V00201 | B-Zellen (19+) [Ly] | 1.2.40.0.34.5.11 | 2‑L | V00202 | T-Zellen (3+) [Ly] | 1.2.40.0.34.5.11 | 2‑L | V00203 | Helfer-T-Z.(4+) [Ly] | 1.2.40.0.34.5.11 | 2‑L | V00204 | Zytotox.T-Z.(8+)[Ly] | 1.2.40.0.34.5.11 | 2‑L | V00205 | aktiv.T-Z.(DR+)[Ly] | 1.2.40.0.34.5.11 | 2‑L | V00206 | NK-Zellen [Ly] | 1.2.40.0.34.5.11 | 2‑L | V00207 | NK-like T-Zellen[Ly] | 1.2.40.0.34.5.11 | 2‑L | V00213 | CD20+ Zellen [Leu] | 1.2.40.0.34.5.11 | 2‑L | 9558-8 | CD20+ Zellen abs. | 2.16.840.1.113883.6.1 | 2‑L | V00238 | CD19+5+ [BZ] | 1.2.40.0.34.5.11 | 2‑L | 9561-2 | CD19+5+ abs. | 2.16.840.1.113883.6.1 | 2‑L | V00239 | CD19+23+ [BZ] | 1.2.40.0.34.5.11 | 2‑L | V00071 | CD19+23+ abs. | 1.2.40.0.34.5.11 | 2‑L | 60436-3 | CD19+25+ [BZ] abs. | 2.16.840.1.113883.6.1 | 2‑L | V00240 | CD19+kappa+ [BZ] | 1.2.40.0.34.5.11 | 2‑L | 50664-2 | CD19+kappa+ abs. | 2.16.840.1.113883.6.1 | 2‑L | V00241 | CD19+lambda+ [BZ] | 1.2.40.0.34.5.11 | 2‑L | 50665-9 | CD19+lambda+ abs. | 2.16.840.1.113883.6.1 | 2‑L | V00242 | K/L-Ratio [B-Zellen] | 1.2.40.0.34.5.11 | 2‑L | V00072 | Klonale Popul. [Leu] | 1.2.40.0.34.5.11 | 2‑L | V00073 | Klonale Popul. abs. | 1.2.40.0.34.5.11 | 2‑L | V00074 | Klonale Pop.[Leu]/KM | 1.2.40.0.34.5.11 | 2‑L | 26997-7 | CD3+25+ [Ly] abs. | 2.16.840.1.113883.6.1 | 2‑L | V00214 | CD52+ Zellen [Leu] | 1.2.40.0.34.5.11 | 2‑L | V00067 | CD52+ Zellen abs. | 1.2.40.0.34.5.11 | 2‑L | V00068 | CD52 AG-Ex.[path.P.] | 1.2.40.0.34.5.11 | 2‑L | V00069 | CD41 AG-Expr.[Thro.] | 1.2.40.0.34.5.11 | 2‑L | V00070 | PAC-1+[Thrombozyten] | 1.2.40.0.34.5.11 | 2‑L | V00208 | B-Zellen(19+)[Ly]/SM | 1.2.40.0.34.5.11 | 2‑L | V00209 | T-Zellen(3+)[Ly]/SM | 1.2.40.0.34.5.11 | 2‑L | V00075 | Helf-T-Z.(4+)[Ly]/SM | 1.2.40.0.34.5.11 | 2‑L | V00076 | Zytot.T-Z(8+)[Ly]/SM | 1.2.40.0.34.5.11 | 2‑L | 18266-7 | CD4/CD8-Ratio /SM | 2.16.840.1.113883.6.1 | 2‑L | 57740-3 | HLA-DR rel. /SM | 2.16.840.1.113883.6.1 | 2‑L | V00210 | akt.T-Z.(DR+)[Ly]/SM | 1.2.40.0.34.5.11 | 2‑L | V00077 | NK-Zellen [Ly]/SM | 1.2.40.0.34.5.11 | 2‑L | V00078 | NK-like T-Z. [Ly]/SM | 1.2.40.0.34.5.11 | 2‑L | V00087 | B-Zellen(19+)abs./BL | 1.2.40.0.34.5.11 | 2‑L | V00088 | T-Zellen(3+)abs./BL | 1.2.40.0.34.5.11 | 2‑L | V00089 | Helf-T-Z.(4+)abs./BL | 1.2.40.0.34.5.11 | 2‑L | V00090 | Zytot.T-Z(8+)abs./BL | 1.2.40.0.34.5.11 | 2‑L | V00083 | CD4/CD8-Ratio /BL | 1.2.40.0.34.5.11 | 2‑L | V00091 | akt.T-Z.(DR+)abs./BL | 1.2.40.0.34.5.11 | 2‑L | V00092 | NK-Zellen abs./BL | 1.2.40.0.34.5.11 | 2‑L | V00093 | NK-like T-Z. abs./BL | 1.2.40.0.34.5.11 | 2‑L | V00079 | B-Zellen(19+)[Ly]/BL | 1.2.40.0.34.5.11 | 2‑L | V00080 | T-Zellen(3+)[Ly]/BL | 1.2.40.0.34.5.11 | 2‑L | V00081 | Helf-T-Z.(4+)[Ly]/BL | 1.2.40.0.34.5.11 | 2‑L | V00082 | Zytot.T-Z(8+)[Ly]/BL | 1.2.40.0.34.5.11 | 2‑L | V00084 | akt.T-Z.(DR+)[Ly]/BL | 1.2.40.0.34.5.11 | 2‑L | V00085 | NK-Zellen [Ly]/BL | 1.2.40.0.34.5.11 | 2‑L | V00086 | NK-like T-Z. [Ly]/BL | 1.2.40.0.34.5.11 | 2‑L | V00445-9 | B-Zellen(19+)[Ly] /L | 1.2.40.0.34.5.11 | 2‑L | V00444-2 | T-Zellen(3+)[Ly] /L | 1.2.40.0.34.5.11 | 2‑L | V00447-5 | Helf-T-Z.(4+)[Ly] /L | 1.2.40.0.34.5.11 | 2‑L | V00448-3 | Zytot.T-Z(8+)[Ly] /L | 1.2.40.0.34.5.11 | 2‑L | V00449-1 | CD4/CD8-Ratio /L | 1.2.40.0.34.5.11 | 2‑L | V00446-7 | NK-Zellen [Ly] /L | 1.2.40.0.34.5.11 | 2‑L | 69052-9 | Befundint.Immunphän. | 2.16.840.1.113883.6.1 | 1‑S | 03050 | Hämatologie Sonstiges | 1.2.40.0.34.5.11 | 2‑L | 59466-3 | Komm.Hämatologie | 2.16.840.1.113883.6.1 | 2‑L | 13514-5 | Hb-Elektrophorese | 2.16.840.1.113883.6.1 | 0‑S | 400 | Gerinnung/Hämostaseologie | 1.2.40.0.34.5.11 | 1‑S | 04140 | Hämostaseologie Globaltests | 1.2.40.0.34.5.11 | 2‑L | 52752-3 | Normotest /KB | 2.16.840.1.113883.6.1 | 2‑L | 52760-6 | Thrombotest /KB | 2.16.840.1.113883.6.1 | 2‑L | 46418-0 | INR /KB | 2.16.840.1.113883.6.1 | 2‑L | 5894-1 | PTZ (Prothrombinz.) | 2.16.840.1.113883.6.1 | 2‑L | 6301-6 | INR | 2.16.840.1.113883.6.1 | 2‑L | V00019 | INR High | 1.2.40.0.34.5.11 | 2‑L | 52753-1 | Normotest | 2.16.840.1.113883.6.1 | 2‑L | 52761-4 | Thrombotest | 2.16.840.1.113883.6.1 | 2‑L | V00233 | Thrombotest INR | 1.2.40.0.34.5.11 | 2‑L | 14979-9 | aPTT | 2.16.840.1.113883.6.1 | 2‑L | 52751-5 | aPTT Fakt.-sens. | 2.16.840.1.113883.6.1 | 2‑L | 3243-3 | Thrombinzeit | 2.16.840.1.113883.6.1 | 2‑L | 6683-7 | Reptilasezeit | 2.16.840.1.113883.6.1 | 2‑L | 3255-7 | Fibrinogen | 2.16.840.1.113883.6.1 | 2‑L | 3256-5 | Fibrinogen Antigen | 2.16.840.1.113883.6.1 | 2‑L | 30240-6 | D-Dimer | 2.16.840.1.113883.6.1 | 2‑L | V00467-3 | D-Dimer ql./B | 1.2.40.0.34.5.11 | 2‑L | 3264-9 | Fibrinopept. A (FPA) | 2.16.840.1.113883.6.1 | 2‑L | 25742-8 | Prothrombinfrg. F1+2 | 2.16.840.1.113883.6.1 | 2‑L | 34701-3 | Heparin-PF4-ind.AK | 2.16.840.1.113883.6.1 | 2‑L | 3274-8 | UF-Heparin (a-Fxa Akt.) | 2.16.840.1.113883.6.1 | 2‑L | 3271-4 | LMW-Heparin (a-Fxa Akt.) | 2.16.840.1.113883.6.1 | 2‑L | 28652-6 | Danaparoid (a-FXa Akt.) | 2.16.840.1.113883.6.1 | 2‑L | V00243 | Fondaparinux (a-Fxa Akt.) | 1.2.40.0.34.5.11 | 2‑L | 49060-7 | Fondaparinux-Spiegel (aFXa) | 2.16.840.1.113883.6.1 | 2‑L | 68979-4 | Rivaroxaban (a-Fxa Akt.) | 2.16.840.1.113883.6.1 | 2‑L | 74871-5 | Rivaroxaban-Spiegel (aFXa) | 2.16.840.1.113883.6.1 | 2‑L | 74214-8 | Apixaban-Spiegel (aFXa) | 2.16.840.1.113883.6.1 | 2‑L | 68981-0 | Argatroban (aFIIa Akt.) | 2.16.840.1.113883.6.1 | 2‑L | V00462-4 | Dabigatran-Spiegel (aFIIa) | 1.2.40.0.34.5.11 | 2‑L | 74220-5 | Dabigatran-Spiegel (aFIIa) | 2.16.840.1.113883.6.1 | 2‑L | 68980-2 | Dabigatran (aFIIa Akt.) | 2.16.840.1.113883.6.1 | 2‑L | 27811-9 | AT III Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 1868-9 | AT III Antigen | 2.16.840.1.113883.6.1 | 2‑L | 24472-3 | PFA 100 / ADP | 2.16.840.1.113883.6.1 | 2‑L | 24471-5 | PFA 100 / Epinephrin | 2.16.840.1.113883.6.1 | 2‑L | V00247 | PFA 100 / P2Y | 1.2.40.0.34.5.11 | 2‑L | 49836-0 | PFA 100 Interprt. | 2.16.840.1.113883.6.1 | 2‑L | V00051 | VASP-Inhib.ADP-med. | 1.2.40.0.34.5.11 | 2‑L | V00052 | Thr.aggr.TRAP-ind./B | 1.2.40.0.34.5.11 | 2‑L | 53813-2 | Thr.aggr.ADP-ind./B | 2.16.840.1.113883.6.1 | 2‑L | 53814-0 | Thr.aggr.ARA-ind./B | 2.16.840.1.113883.6.1 | 2‑L | V00055 | Thr.aggr.Ristoc./B | 1.2.40.0.34.5.11 | 2‑L | 52789-5 | Clotting Time NATEM | 2.16.840.1.113883.6.1 | 2‑L | 52768-9 | Clot Form.Time NATEM | 2.16.840.1.113883.6.1 | 2‑L | 52778-8 | Max.Clot Firmn.NATEM | 2.16.840.1.113883.6.1 | 2‑L | 52784-6 | Maximal Lyse NATEM | 2.16.840.1.113883.6.1 | 2‑L | 52773-9 | Clotting Time EXTEM | 2.16.840.1.113883.6.1 | 2‑L | 52770-5 | Clot Form.Time EXTEM | 2.16.840.1.113883.6.1 | 2‑L | 52783-8 | Max.Clot Firmn.EXTEM | 2.16.840.1.113883.6.1 | 2‑L | 52786-1 | Maximal Lyse EXTEM | 2.16.840.1.113883.6.1 | 2‑L | 52776-2 | Clotting Time INTEM | 2.16.840.1.113883.6.1 | 2‑L | 52771-3 | Clot Form.Time INTEM | 2.16.840.1.113883.6.1 | 2‑L | 52781-2 | Max.Clot Firmn.INTEM | 2.16.840.1.113883.6.1 | 2‑L | 52787-9 | Maximal Lyse INTEM | 2.16.840.1.113883.6.1 | 2‑L | 52775-4 | Clotting Time HEPTEM | 2.16.840.1.113883.6.1 | 2‑L | 52780-4 | Max.Clot Firmn.FIBT. | 2.16.840.1.113883.6.1 | 2‑L | 52774-7 | Clotting Time APTEM | 2.16.840.1.113883.6.1 | 2‑L | 11067-6 | Blutungszeit n. Duke | 2.16.840.1.113883.6.1 | 2‑L | 3183-1 | Ger.zeit Lee/White | 2.16.840.1.113883.6.1 | 2‑L | V00041 | Blutgerinn.Bef.int.. | 1.2.40.0.34.5.11 | 2‑L | 67790-6 | Thrombelastographie | 2.16.840.1.113883.6.1 | 1‑S | 04150 | Einzelfaktoranalysen | 1.2.40.0.34.5.11 | 2‑L | 3289-6 | Faktor II Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 27813-5 | Faktor II Antigen | 2.16.840.1.113883.6.1 | 2‑L | 3193-0 | Faktor V Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3191-4 | Faktor V Inhibitor | 2.16.840.1.113883.6.1 | 2‑L | 3198-9 | Faktor VII Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3218-5 | Faktor X Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3209-4 | Faktor VIII Akt. | 2.16.840.1.113883.6.1 | 2‑L | 3204-5 | Faktor VIII Inhib. | 2.16.840.1.113883.6.1 | 2‑L | 3187-2 | Faktor IX Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3185-6 | Faktor IX Inhibitor | 2.16.840.1.113883.6.1 | 2‑L | 3226-8 | Faktor XI Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3232-6 | Faktor XII Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 27815-0 | Faktor XIII Akt. | 2.16.840.1.113883.6.1 | 2‑L | V00006 | FXIII Akt.Clot-Lysis | 1.2.40.0.34.5.11 | 2‑L | 52754-9 | HMWK Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 28659-1 | Präkallikrein | 2.16.840.1.113883.6.1 | 2‑L | 52759-8 | Präkallikrein Akt. | 2.16.840.1.113883.6.1 | 2‑L | 6014-5 | vWF-Ristoc.Kof.Akt. | 2.16.840.1.113883.6.1 | Dieses Value Set beinhaltet 3680 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt. |
| 0‑L | OTH | anders | 2.16.840.1.113883.5.1008 |
|
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben. |